Allogeneic stem cell transplantation in therapy-related acute myeloid leukemia and myelodysplastic syndromes: impact of patient characteristics and timing of transplant

References

• Brunning RD, Matutes E, Harris NL, . Acute myeloid leukaemia: introduction. Jaffe ES, Harris NL, Stein H, . World Health Organization classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2001. 77–80, 89–91.
   Google Scholar
• Ellis M, Ravid M, Lishner M. A comparative analysis of alkylating agent and epipodophyllotoxin-related leukemias. Leuk Lymphoma 1993;11:9–13.
   PubMed Web of Science ®Google Scholar
• Leone G, Voso MT, Sica S, . Therapy related leukemias: susceptibility, prevention and treatment. Leuk Lymphoma 2001;41: 255–276.
   PubMed Web of Science ®Google Scholar
• Mauritzson N, Albin M, Rylander L, . Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976-1993 and on 5098 unselected cases reported in the literature 1974-2001. Leukemia 2002;16:2366–2378.
   PubMed Web of Science ®Google Scholar
• Smith SM, Le Beau MM, Huo D, . Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series. Blood 2003;102:43–52.
   PubMed Web of Science ®Google Scholar
• Olney HJ, Mitelman F, Johansson B, . Unique balanced chromosome abnormalities in treatment-related myelodysplastic syndromes and acute myeloid leukemia: report from an international workshop. Genes Chromosomes Cancer 2002;33:413–423.
   PubMed Web of Science ®Google Scholar
• Bloomfield CD, Archer KJ, Mrózek K, . 11q23 balanced chromosome aberrations in treatment-related myelodysplastic syndromes and acute leukemia: report from an international workshop. Genes Chromosomes Cancer 2002;33:362–378.
   PubMed Web of Science ®Google Scholar
• Witherspoon RP, Deeg HJ, Storer B, . Hematopoietic stem-cell transplantation for treatment-related leukemia or myelodysplasia. J Clin Oncol 2001;19:2134–2141.
   PubMed Web of Science ®Google Scholar
• Litzow MR, Tarima S, Pérez WS, . Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia. Blood 2010;115:1850–1857.
   PubMed Web of Science ®Google Scholar
• Grimwade D, Walker H, Oliver F, . The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 1998;92:2322–2333.
   PubMed Web of Science ®Google Scholar
• Cheson BD, Bennett JM, Kopecky KJ, . Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia. J Clin Oncol 2003;21:4642–4649.
   PubMed Web of Science ®Google Scholar
• Sorror ML, Maris MB, Storb R, . Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 2005;106:2912–2919.
   PubMed Web of Science ®Google Scholar
• Przepiorka D, Weisdorf D, Martin P, . Consensus conference on acute GvHD grading. Bone Marrow Transplant 1995;15:825–828.
   PubMed Web of Science ®Google Scholar
• Rowlings PA, Przepiorka D, Klein JP, . IBMTR severity index for grading acute GvHD: retrospective comparison with Glucksberg grade. Br J Haematol 1997;97:855–864.
   PubMed Web of Science ®Google Scholar
• Shulman HM, Sullivan KM, Weiden PL, . Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980;69:204–217.
   PubMed Web of Science ®Google Scholar
• Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988;16:1140–1154.
   Web of Science ®Google Scholar
• Kröger N, Brand R, van Biezen A, . Risk factors for therapy-related myelodysplastic syndrome and acute myeloid leukemia treated with allogeneic stem cell transplantation. Haematologica 2009;94:542–549.
   PubMedGoogle Scholar
• de Witte T, Hermans J, Vossen J, . Haematopoietic stem cell transplantation for patients with myelodysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Br J Haematol 2000;110:620–630.
   PubMed Web of Science ®Google Scholar
• Schoch C, Kern W, Schnittger S, . Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML. Leukemia 2004;18:120–125.
   PubMed Web of Science ®Google Scholar
• Kern W, Haferlach T, Schnittger S, . Prognosis in therapy-related acute myeloid leukemia and impact of karyotype. J Clin Oncol 2004;22:2510–2511.
   PubMed Web of Science ®Google Scholar
• Armand P, Kim HT, DeAngelo DJ, . Impact of cytogenetics on outcome of de novo and therapy-related AML and MDS after allogeneic transplantation. Biol Blood Marrow Transplant 2007;13:655–664.
   PubMed Web of Science ®Google Scholar
• Schlenk RF, Döner K, Mack S, . Prospective evaluation of allogeneic hematopoietic stem-cell transplantation from matched related and matched unrelated donors in younger adults with high-risk acute myeloid leukemia: German-Austrian trial AMLHD98A. J Clin Oncol 2010;28:4642–4648.
   PubMed Web of Science ®Google Scholar
• Alatrash G, de Lima M, Hamerschlak N, . Myeloablative reduced-toxicity i.v. busulfan-fludarabine and allogeneic hematopoietic stem cell transplant for patients with acute myeloid leukemia or myelodysplastic syndrome in the sixth through eighth decades of life. Biol Blood Marrow Transplant 2011 Feb 18. [Epub ahead of print]
   Google Scholar
• Tallman MS, Rowlings PA, Milone G, . Effect of postremission chemotherapy before human leukocyte antigen-identical sibling transplantation for acute myelogenous leukemia in first complete remission. Blood 2000;96:1254–1258.
   PubMed Web of Science ®Google Scholar
• Meyer E, Beyersmann J, Bertz H, . Risk factor analysis of blood stream infection and pneumonia in neutropenic patients after peripheral blood stem-cell transplantation. Bone Marrow Transplant 2007;39:173–178.
   PubMed Web of Science ®Google Scholar